एपीए उद्धरण

Cao, Z., Ren, D., Ha, T., Liu, L., Wang, X., Kalbfleisch, J., . . . Li, C. (2012). CpG-ODN, the TLR9 agonist, attenuates myocardial ischemia/reperfusion injury: Involving activation of PI3K/Akt signaling.

शिकागो स्टाइल उद्धरण

Cao, Zhijuan, et al. CpG-ODN, the TLR9 Agonist, Attenuates Myocardial Ischemia/reperfusion Injury: Involving Activation of PI3K/Akt Signaling. 2012.

एमएलए उद्धरण

Cao, Zhijuan, et al. CpG-ODN, the TLR9 Agonist, Attenuates Myocardial Ischemia/reperfusion Injury: Involving Activation of PI3K/Akt Signaling. 2012.